Cargando…
Regarding: ‘Epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795440/ https://www.ncbi.nlm.nih.gov/pubmed/19997108 http://dx.doi.org/10.1038/sj.bjc.6605474 |
| _version_ | 1782175433542860800 |
|---|---|
| author | Schwarzer, G |
| author_facet | Schwarzer, G |
| author_sort | Schwarzer, G |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2795440 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27954402010-12-14 Regarding: ‘Epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’ Schwarzer, G Br J Cancer Editorial Nature Publishing Group 2009-12-15 2009-12-08 /pmc/articles/PMC2795440/ /pubmed/19997108 http://dx.doi.org/10.1038/sj.bjc.6605474 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Editorial Schwarzer, G Regarding: ‘Epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’ |
| title | Regarding: ‘Epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’ |
| title_full | Regarding: ‘Epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’ |
| title_fullStr | Regarding: ‘Epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’ |
| title_full_unstemmed | Regarding: ‘Epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’ |
| title_short | Regarding: ‘Epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’ |
| title_sort | regarding: ‘epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’ |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795440/ https://www.ncbi.nlm.nih.gov/pubmed/19997108 http://dx.doi.org/10.1038/sj.bjc.6605474 |
| work_keys_str_mv | AT schwarzerg regardingepoetinbtreatmentinpatientswithcancerchemotherapyinducedanaemiatheimpactofinitialhaemoglobinandtargethaemoglobinlevelsonsurvivaltumourprogressionandthromboembolicevents |